The Case For Making A Russian Connection
While most of the attention paid to Russia of late has been in relation to its election meddling, investors may have a different reason to… Read More »The Case For Making A Russian Connection
While most of the attention paid to Russia of late has been in relation to its election meddling, investors may have a different reason to… Read More »The Case For Making A Russian Connection
Successful trading requires not only learning what to do, but also knowing what mistakes to avoid (like the plague, in some cases). Here are 13… Read More »Trading’s Unlucky 13
Of the five cannabis companies covered by Morningstar, there are three its analysts believe offer investors attractive risk-adjusted upside at current prices. But do any… Read More »Marijuana With Moat?
The most recent Fortune 500 list of the largest U.S. companies by revenue includes a record 33 companies led by female CEOs. Here are eight… Read More »Female CEOs Are Leading These Stocks Higher
If the FDA enacts a “maximum nicotine” policy within the next 15 years, it is likely to serve a massive blow to tobacco companies –… Read More »Maximum Damage From “Maximum Nicotine”
With one forecast predicting that cannabidiol sales in the U.S. will soar to $22 billion by 2022, it is no wonder that CBD is garnering… Read More »A Sneakier, Smarter, And More Stable CBD Play
While it’s currently a small subset of the real estate sector, this “cold” investment is really heating up thanks to food delivery services such as… Read More »A “Cold” Investment That’s Heating Up
While this month’s Federal Reserve meeting is in the books, another – and potentially more consequential one for interest rates – is right around the… Read More »A Contrarian Way To Play The Fed
When it comes to finding sources of strong returns among healthcare stocks, investors may be better off focusing on businesses rather than potential breakthroughs. In… Read More »Healthcare Stocks: Business Over Breakthrough
Healthcare stocks have lagged overall this year, in large part due to political and regulatory risks. Some healthcare stocks, however, appear to be shielded from… Read More »Healthcare Stocks With Political Immunity